ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Effect of IOP-lowering treatment and Pentoxifylline on retrobulbar blood flow in normal tension glaucoma: a color doppler imaging study.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the effect of combining topical intraocular pressure (IOP)-lowering medications with oral pentoxifylline on ocular blood flow in patients with normal tension glaucoma (NTG), using Color Doppler Imaging (CDI).
methodsIn this pilot study, we retrospectively identified NTG patients who underwent IOP-lowering therapy followed by oral pentoxifylline administration. Three study visits were considered: baseline (V1) without therapy, after IOP-lowering therapy (V2), and following the addition of oral pentoxifylline (V3). Each visit included: IOP and blood pressure measurements, CDI of central retinal artery (CRA), and short posterior ciliary arteries (SPCAs). CDI parameters analyzed included peak systolic velocity (PSV), end diastolic velocity (EDV), and resistive index (RI). The healthy control group with CDI of ocular vessels was used to establish a threshold for “impaired” versus “normal” flow based on the 5th percentile of CDI parameters.
resultsNine NTG patients (18 eyes) were considered. Following topical IOP-lowering therapy (V2), IOP decreased significantly (16.50 ± 2.96 mmHg at V1 to 12.33 ± 1.80 mmHg at V2; p < 0.0001), PSV in impaired CRA showed a notable increase (p < 0.0079), though blood flow changes in SPCAs were minimal. With the addition of pentoxifylline at V3, PSV and EDV significantly improved across impaired SPCAs. No changes were noted in CDI parameters in the normal SPCAs.
conclusionsCombined therapy with topical IOP-lowering medications and oral pentoxifylline in NTG patients enhanced CDI parameters in vessels with initially impaired flow. This approach may provide a beneficial, vascular-targeted treatment for NTG management.
Indexed as
Identifiers
41729284What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.